As of 2024-12-15, the Fair Value of Lipigon Pharmaceuticals AB (LPGO.ST) is -0.68 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.19 SEK, the upside of Lipigon Pharmaceuticals AB is -451.93%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -82.23 | -75.41 | -24.26 | - | -60.63 | |
| YoY growth | -409.58% | 8.29% | 67.83% | - | -111.15% | |
| Market Cap (mil) | 28.78 |
| P/E | |
| Forward P/E |
| EPS | -0.14 |
| Avg earnings growth rate | -111.15% |
| TTM earnings | -20.25 |